The US Orphan Drug Act: Rare disease research stimulator or commercial opportunity?

Title
The US Orphan Drug Act: Rare disease research stimulator or commercial opportunity?
Authors
Keywords
-
Journal
HEALTH POLICY
Volume 95, Issue 2-3, Pages 216-228
Publisher
Elsevier BV
Online
2009-12-30
DOI
10.1016/j.healthpol.2009.12.001

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started